CAT-152 CAT 152
We provide customized and high-quality Lerdelimumab product for your project.
Lerdelimumab is a human monoclonal antibody that targets TGF beta 2. Lerdelimumab is developed to reduce scarring after glaucoma drainage surgery.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View